Key Sessions
Patricia Bradley
Healthtech Business Scale Up - Setting Healthtech Companies up for Success
MindMaze
Jonathan Machado
Time for Revival? Healthtech & Digital Health Investment
Samsung NEXT
Ziv Bar-Joseph
Defining our AI Future – Operationalising AI to Deliver Business & Patient Benefits
Sanofi
Liesl Oldstone
DTx 2.0 – Building the Right Digital Therapeutic Business Model for Long-Term Growth & Revenue
AppliedVR
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 – Wednesday 11th September - EST/EDT (Eastern Daylight, GMT-4)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 1 – Wednesday 11th September - EST/EDT (Eastern Daylight, GMT-4)
search
Streams
Formats
Showing 1 of 1 Streams
Registration & Breakfast
08:00 - 09:00
Registration & Breakfast
Showing 1 of 1 Streams
HEALTHTECH LEADERS
09:00 - 09:10
Welcome Address
- Nadia Konneh - Senior Conference Director, Healthtech Lead, LSX
09:10 - 09:50
Defining our AI Future – Operationalising AI to Deliver Business & Patient Benefits
While the excitement and anticipation is huge, what is the actual way forward with AI? How can organisations operationalise it to deliver business and patient benefits?
- Addressing barriers to adoption so we can build out scale with AI
- Exploring the bridge between commercial and R&D
- Maintaining the human touch - How can we use AI to improve the patient experience?
- What are the safeguards for applications of AI?
- AI use in Pharma- Analytics, leveraging RWE, AI modelling and increasing efficiency & effectiveness
- Ziv Bar-Joseph - VP, Head, R&D Data & Computational Sciences, Sanofi
- Amir Zur - Executive Director, Head of R&D Digital Head Products, Takeda
- Andreas Cleve - CEO, Corti AI
09:50 - 10:30
DTx 2.0 – Building the Right Digital Therapeutic Business Model for Long-Term Growth & Revenue
- Which digital therapeutics business models are working in the real world? What is the business model of the future?
- Given the issues with reimbursement, what are companies doing to survive?
- DTx-pharma partnerships & collaborations – Are Pharma moving away from DTx?
- Addressing investor hesitancy and raising funds
- Defining clear value proposition to address customers’ unmet needs
- The DTx sweet spot is behavioural health– How can it be applied to other disease areas? How valuable would this be to the healthcare sector?
- Liesl Oldstone - VP Health Economics & Market Access, AppliedVR
- Kevin McRaith - CEO, WellDoc
- David Klein - CEO, Click Therapeutics
- Joe Perekupka - CEO, Freespira
Showing 1 of 1 Streams
Morning Break
10:30 - 11:00
Morning Break
Showing 1 of 1 Streams
HEALTHTECH LEADERS
11:00 - 11:50
Streamlining Clinical Trials for Patients & Clinicians Through Digital
- Co-creating a solution with patients and medical professionals
- Scaling digital clinical trials solutions
- Achieving diversity, equity, and inclusion in decentralized trials
- Partnering for success- Is a unified digital clinical trial solution the answer?
- Investing in clinical trial tech – investor perspectives
- John Wagner - Chief Medical Officer, Koneksa
- Jodi Akin - Founding CEO, Hawthorne Effect
- Sarah Valentine - Partnerships Lead, Life Sciences, Digital Medicine Society (DiMe)
- Ben Casavant - Co-Founder & CEO, Tasso
11:50 - 12:40
Overcoming Pharma & Medtech’s Digital Transformation Challenges – How to Change for Real?
- Adopting a customer-centric approach and transforming the experience of the end user
- How are life science companies continuing to build their digital strategy and capabilities?
- Discussing the persisting challenges in scaling digital and analytics
- Examining the rise in digital software adoption and development objectives
- A look at future digitized go-to-market models for pharma and medtech companies
- Saurav Gupta - Senior Director, Platform Strategy & Implementation – Connected Care, Eli Lilly
- Amy West - Head of US Digital Transformation & Innovation, Novo Nordisk
- Nishtha Jain - Head of Innovation & Digital Technology, Takeda
Showing 1 of 1 Streams
Networking Break
12:40 - 13:40
Lunch Break
Showing 1 of 1 Streams
HEALTHTECH LEADERS
13:40 - 14:30
Healthtech Business Scale Up - Setting Healthtech Companies up for Success
- Demonstrating real value, a path to profitability and scalable unit economics
- Navigating investment landscapes and securing funding for scale-up initiatives
- Leveraging collaborations for mutual growth and innovation
- Prioritizing user experience in the design and scalability of digital health products
- Ensuring regulatory compliance at scale
- Patricia Bradley - Global Chief Commercial Officer, MindMaze
- Sam Oddson - Co-Founder & Chief Clinical Officer, Sidekick Health
- Katerina Fialkovskaya - Venture Investor, Philips Ventures
14:30 - 15:20
Building Sustainable, Value-Based Strategic Digital Health Partnerships
- Evaluating digital health and DTx partnerships/ collaborations – how well are they working?
- Navigating diverse partnership models
- Are pharmaceutical companies the preferred partners for digital health start-ups?
- Investor and pharma expectations from digital health companies and vice versa
- Sophie Park - Managing Director, G4A Investments & Partnerships, Bayer G4A
- Catherine Blanchette - Head of Digital Strategic Partnerships, Sanofi
- Ameya Phadke - Patients Non-Pharma Solutions Leader, Chiesi
- Hassan Naqvi - Head of Digital Health Partnerships, AstraZeneca
- Nathan Sundheimer - Head, US Healthcare Partnerships, Plug and Play
Showing 1 of 1 Streams
Networking Break
15:20 - 15:50
Afternoon Break
Showing 1 of 1 Streams
HEALTHTECH LEADERS
15:50 - 16:40
AI Forward- Pursuing the Safe, Responsible and Meaningful Integration of Generative AI in Healthcare
- Leveraging GenAI tools (including large language models) to optimise care delivery
- The use of GenAI help solve the challenge of patient engagement
- Does the Biden AI framework provide sufficient guardrails for companies? What legislation is needed?
- Scaling up equitable and inclusive AI healthcare models
- Neil Sahota - AI Advisor, United Nations
- Marcy Rudowitz - Director, Medical Engagement, Moderna
- Dale Cyr - CEO & Executive Director, Inteleos
16:40 - 17:30
Time for Revival? Healthtech & Digital Health Investment
- What factors are driving digital health investor investment decisions, and which areas are primed for growth?
- Are AI-enabled prescription digital therapeutics an investment priority?
- The continued importance of healthtech and digital health companies demonstrating real value, a path to profitability and scalable unit economics
- Evaluating the investment opportunities in emerging tech
- How do the financial stresses and growing needs of health systems impact the greater digital health investment landscape?
- Jonathan Machado - Managing Director, Samsung NEXT
- Nancy Brown - General Partner, Oak HC/FT
- Tunde Akinniranye - Investor, 7wire Ventures
- Ian Chiang - Partner, Flare Capital
Showing 1 of 1 Streams
Networking Break
17:30 - 18:20
Drinks Reception
18:20 - 19:50
Networking Party
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats